A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.
Eur J Gynaecol Oncol
; 32(3): 253-8, 2011.
Article
en En
| MEDLINE
| ID: mdl-21797111
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Talidomida
/
Carcinoma
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Carboplatino
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Eur J Gynaecol Oncol
Año:
2011
Tipo del documento:
Article